Results 151 to 160 of about 784,460 (315)

BIOCHEMICAL MARKERS IN SERUM AND URINE IN THE WORKUP OF PATIENTS WITH NEUROENDOCRINE TUMORS

, 2016
N. V. Lyubimova, Н. Е. Кушлинский   +1 more
openalex   +2 more sources

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Procalcitonin as a potential tumor marker for fibrolamellar hepatocellular carcinoma: Insights from three patients and a literature review. [PDF]

Front Med (Lausanne)
Özden İ, Kaya S, Dübüş T, Yücesan A, Bulut N, Büyüktalancı E.   +5 more
europepmc   +1 more source

Serum Bone Morphogenetic Proteins, Hepcidin ,Ferroportin , Chitotriosidase and Alkaline Phosphatase Activity as Tumor Markers in Detection and Staging of Breast Cancer

Shatha Ali, Furat Y. Mohsen, Zahraa Ali
openalex   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Retrospective analysis of preoperative serum tumor marker levels and their correlation with pathological characteristics and prognosis in cervical cancer patients. [PDF]

Front Genet
Shen Y, Kang M.
europepmc   +1 more source

How effective is the CA 19.9 tumor marker in monitoring treatment response in patients with gastrointestinal cancers?

Tripdatabase
openalex   +1 more source

Immunofluorescent analyses of tumor marker beta-III tubuilin expression in tumor and ajacent normal lung tissue derived from patients with non-small cell lung cancer

, 2016
I. A. Mamichev, Т. А. Богуш, E. A. Dudko, O. M. Ryabinina, А. Н. Гришанина, V. E. Kirsanov, B. E. Polotsky, М. М. Давыдов   +7 more
openalex   +2 more sources

Significance of tumor markers in lung cancer [PDF]

, 2006
P. P. Mumbarkar, A. S. Raste, M. S. Ghadge   +2 more
openalex   +1 more source

Translating whole‐genome doubling into precision medicine in cancer

Molecular Oncology, EarlyView.
Whole‐genome doubling creates a WGD‐positive tumor state characterized by persistent chromosomal instability, karyotypic diversification, and cellular stress. These same biological pressures drive aggressive tumor evolution while exposing therapeutic vulnerabilities, providing a rationale for WGD‐informed precision medicine. Whole‐genome doubling (WGD)
Sejung Lee, Junghyeok Lim, Jinhyuk Bhin
wiley   +1 more source